AptaBio Therapeutics Inc
KOSDAQ:293780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AptaBio Therapeutics Inc
KOSDAQ:293780
|
KR |
|
T
|
Tesla Inc
XHAN:TL0
|
US |
|
Four Corners Property Trust Inc
F:4Z1
|
US |
|
D
|
DRB-HICOM Bhd
KLSE:DRBHCOM
|
MY |
|
Activeops PLC
F:95D
|
UK |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
|
Krispy Kreme Inc
F:9YM
|
US |
|
G
|
Gap Inc
DUS:GAP
|
US |
|
C
|
Chips&Media Inc
KOSDAQ:094360
|
KR |
|
T
|
TSA Group Bhd
KLSE:TSA
|
MY |
Shareholder Yield
Current shareholder yield for AptaBio Therapeutics Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
AptaBio Therapeutics Inc
| Average Annual Return | -22.96% |
| Standard Deviation of Annual Returns | 44.23% |
| Max Drawdown | -93% |
| Market Capitalization | 143B KRW |
| Shares Outstanding | 28 090 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
AptaBio Therapeutics Inc's latest stock split occurred on Aug 24, 2021
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
Before the split, AptaBio Therapeutics Inc traded at 101300 per share. Afterward, the share price was about 47600.
The adjusted shares began trading on Aug 24, 2021. This was the only stock split in AptaBio Therapeutics Inc's history.